Spruce Biosciences (SPRB)
(Delayed Data from NSDQ)
$8.38 USD
-0.51 (-5.71%)
Updated Sep 19, 2025 03:31 PM ET
2-Buy of 5 2
C Value F Growth A Momentum D VGM
Fundamental Charts
About Market Cap
As of the previous market close, Spruce Biosciences, Inc. has a market cap of $4.99M, which represents its share price of $8.88 multiplied by its outstanding shares number of 0.56M. As a small-cap company, SPRB's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
SPRB 8.38 -0.51(-5.71%)
Will SPRB be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for SPRB based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SPRB
Puma Biotech (PBYI) Surpasses Q2 Earnings and Revenue Estimates
Curis (CRIS) Reports Q2 Loss, Beats Revenue Estimates
SPRB: What are Zacks experts saying now?
Zacks Private Portfolio Services
Illumina (ILMN) Q2 Earnings and Revenues Surpass Estimates
Invivyd, Inc. (IVVD) Reports Q4 Loss, Tops Revenue Estimates
Agenus (AGEN) Reports Q4 Loss, Lags Revenue Estimates
Other News for SPRB
Biotech Alert: Searches spiking for these stocks today
Biotech Alert: Searches spiking for these stocks today
Biotech Alert: Searches spiking for these stocks today
Biotech Alert: Searches spiking for these stocks today
12 Health Care Stocks Moving In Monday's Intraday Session